YOLFTbeta
Evonik Industries AG

Evonik Industries AG

0QDS · LSE

21.06EUR+0.08 (+0.38%)

Price History

Full chart

Market Stats

Previous Close20.98
Open21.02
Day Range21.02 – 21.06
52-Week Range11.75 – 20.43
Volume2
Market Cap13.46B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield6.32%
Beta0.55
50-Day Avg18.41
200-Day Avg18.94

About

Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent for the paper and textile industries; fumed and precipitated silicas and silanes for the automotive, tire, electronics, and cosmetics industries; and D-/L-methionine and lysine for animal nutrition. Its Custom Solutions segment provides additives for coatings, adhesives, sealants, polyurethane foams, and lubricants for the cosmetic, cleaning, and pharmaceutical industries. The Infrastructure segment engages in the infrastructure activities and offers butadiene, MTBE, butene-1, isononanol, and DINP for use in the plastic and packaging industries, production of rubber and fuels, and as plasticizers in the construction and automotive sectors. The company was founded in 1847 and is headquartered in Essen, Germany.

Company Details

  • CEODr. Claus Rettig
  • Employees30.36K
  • HeadquartersRellinghauser Strasse 1-11, Essen, Germany, 45128, UK
  • Websitehttps://evonik.com

Leadership

  • Mr. Thomas WesselChief Human Resources Officer, Labor Relations Director & Member of Executive Board · b. 1963
  • Ms. Lauren KjeldsenCOO of Custom Solutions & Member of the Management Board
  • Dr. Claudine MollenkopfCOO of Advanced Technologies & Member of the Management Board · b. 1966
  • Dr. Claus RettigInterim CEO & Deputy Chairman of the Management Board
  • Mr. Michael Rauch L.L.M., M.B.A.CFO & Member of Executive Board · b. 1972
  • Dr. Wilfried OstendorfHead of Production and Technology
  • Mr. Tim LangeHead of Investor Relations
  • Mr. Thomas MahlstedtVice President M&A, Corporate Legal & Compliance
  • Mr. Christian SchmidHead of Corporate Communications · b. 1971
  • Dr. Stefan MackHead of the Methionine & Derivatives Product Line

Financials

Income Statement

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-31
Total Revenue12.73B14.38B13.27B13.11B12.20B--
Growth (%)-+12.97%-7.76%-1.20%-6.93%--
Cost of Revenue8.53B9.90B9.27B9.41B8.83B--
Gross Profit4.20B4.48B4.00B3.69B3.37B--
Gross Margin32.97%31.13%30.12%28.19%27.59%--
Operating Expense2.90B3.25B2.95B2.61B2.55B--
Operating Income1.30B1.23B1.05B1.09B819.00M--
Operating Margin10.19%8.52%7.91%8.29%6.71%--
Net Income844.00M713.00M932.00M2.11B465.00M--
Net Income Margin6.63%4.96%7.02%16.07%3.81%--
Interest Expense000000-
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%--

Balance Sheet

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-31
Total Assets19.64B19.94B20.28B22.02B20.90B--
Total Liabilities11.99B12.51B12.55B13.05B12.88B--
Total Equity7.66B7.43B7.73B8.97B8.01B--
Cash4.62B1.00B988.00M1.17B563.00M--
Total Debt3.23B3.69B3.68B3.70B3.54B--

Cash Flow

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow1.76B1.55B1.76B1.32B1.73B1.81B1.65B--
Investing Cash Flow-883.00M-5.18B-973.00M-292.00M-570.00M-1.07B-777.00M--
Financing Cash Flow1.38B23.00M-801.00M-856.00M-1.73B-856.00M-672.00M--
Capital Expenditure948.00M1.04B948.00M880.00M956.00M886.00M865.00M00
Dividends Paid536.00M536.00M536.00M536.00M536.00M536.00M545.00M--

Earnings

Report DateJun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 21, 2024May 8, 2024Aug 1, 2024Nov 6, 2024Mar 5, 2025May 12, 2025Aug 1, 2025Nov 4, 2025Mar 4, 2026May 8, 2026Aug 4, 2026Nov 3, 2026
EPS Estimate------------------------------------------------0.410.290.090.280.540.56
EPS Actual0.413.150.220.360.300.240.330.550.900.400.280.520.350.480.460.340.500.470.230.620.660.710.010.530.493.170.350.280.240.320.150.400.470.500.230.670.640.46-0.610.10-0.58-0.21-0.310.33-0.010.48-0.330.500.26-0.230.040.270.18-
Surprise-------------------------------------------------37.20%-178.45%-57.11%-4.21%-66.61%-
Timing------------------------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap13.46B
Enterprise Value13.06B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book0.00
Book Value16.87
Revenue (TTM)14.11B
Gross Profit (TTM)3.53B
EBITDA1.71B
Profit Margin0.86%
Operating Margin4.14%
Return on Equity1.60%
Return on Assets3.08%
Shares Outstanding0
Shares Float252.00M
Beta0.55
Dividend Yield6.32%
Dividend Rate0.00
Payout Ratio3.85%

Dividends

20261×
1.00Jun 4, 2026
20251×
1.17May 29, 2025
20241×
1.17Jun 5, 2024
20231×
1.17Jun 1, 2023
20221×
1.17May 26, 2022
20211×
1.15Jun 3, 2021
20202×
0.58Sep 1, 20200.57May 28, 2020
20191×
1.15May 29, 2019
20181×
1.15May 24, 2018
20171×
1.15May 24, 2017
20161×
1.15May 19, 2016
20151×
1.00May 20, 2015
20141×
1.00May 21, 2014